Autorisation d’accès précoce refusée à la spécialité TEZSPIRE (Tézépélumab).
Voir aussi
Décision d'accès précoce
22/12/2022
eNrlWN9v2jAQfu9fgfJuAhRKmALVxtoNadUYLdq0F2TsA8xMnPoHpf3r5xC60ilZW1O/dC/I+Jzvzvbdd3eOTzcrXlmDVEwk3aBerQUVSIigLJl3g/HVOYqC095RvMRr/LCsYddV6/WgQjhWqhtk0uoUcKKqPy6+fAT7Pcigd1SJxXQJRD9aZzTj1c9YLS5wmq2pxGvBaGUFeiFoN0iN3s5WYqWltaJ3I+QvlWICcbib2ZcuJ839+TjMwJ6BahTILziZF4LOpBMmMVJCovtYw1zI20LoVNL6pNGJTuqdyEkJUyNQwkgCQ6wXQynWjAIt3gbmCpyUzG7oJcg1B50pKQQPl2SlnMDxEm9GcD0oNvq9lfb1RqMaqrejqNVqN09qzbbbYcm9oyp2H7uJMJ0cH3eiZtQOZzKkQFjm5Shp1BoNlKkOKQkVrBA1qN5CdgGsphLQVm7niOAc5mAFiGO0wEYDsj9CMr2dVDixg1RIbQdIwsyo3VoKK5zYIUWYEFAolTZ0yD2SSq0pmGcoGu5UyiQ4esww0809+QpT/cd+70mPhOsnfZIylXJ8W12q1PWosMRWDNKyk7+NZDu4kpYvuT2zv/ATw3n4QqvHOzbzZHFGln1hEl1Caucj14PoCxsbm/IbdeNhvdn5IgP1erB3IinOQUMz5Yy4Eq2lQgNKj0eDcp59+xT1ASsYS38c9Z0lVNyo1+e+fV/zZP32XngxKJk0onar03avgn5aty7JxWdGihRCy4lMHUJ1g2QmDiU5GynFUPdx8sZDZFuwCoI5lJSsyJGFbWzcV9jeos9fZOeCQtBPZ1euTvvNgLy93P4thGa0+8fd3FKUj7xnQ6TU8JcHXM46/2xmcvZpRsdu1bmRxaS20DpV78JwgVUedlUb0f9HGtyrh/y1dl6KrrwIzZOJJ9OneY3wfJ9xDf+nSrJD24zd97t2plCHlgYOuIc8U3jj88HZ66eIhx7Dm9nDR5TmT822H8DacpOvitBMi1+XDkpK9l6Tc2nJ4etsxkre20r9Mg7zt77eURxm73y9o9+aK7cE
L6tVApZmFBWk4EJq